I. The differentiation of opiate receptors: Introduction

Life Sciences ◽  
1981 ◽  
Vol 28 (14) ◽  
pp. 1543-1545 ◽  
Author(s):  
Martin W. Adler
Keyword(s):  
Diabetes ◽  
1987 ◽  
Vol 36 (10) ◽  
pp. 1173-1177 ◽  
Author(s):  
D. A. Brase ◽  
Y. H. Han ◽  
W. L. Dewey
Keyword(s):  

1980 ◽  
Vol 61 (4) ◽  
pp. 389-391 ◽  
Author(s):  
Walter Fratta ◽  
Mariano Casu ◽  
Angelo Balestrieri ◽  
Andrea Loviselli ◽  
Giovanni Biggio ◽  
...  
Keyword(s):  

1985 ◽  
Vol 113 (3) ◽  
pp. 465-466 ◽  
Author(s):  
Andrew L. Gundlach ◽  
Brian L. Largent ◽  
Solomon H. Snyder
Keyword(s):  

1998 ◽  
Vol 125 (6) ◽  
pp. 576-578
Author(s):  
Yu. B. Lishmanov ◽  
L. N. Maslov ◽  
A. V. Krylatov
Keyword(s):  

1990 ◽  
Vol 17 (3) ◽  
pp. 177-181
Author(s):  
Peter S. Eriksson ◽  
Elisabeth Hansson ◽  
Lars Rönnbäck

The presence of μ-opioid receptors was demonstrated as effects of receptor stimulation on PGE1-induced cAMP accumulation in neuronal-enriched primary cultures from rat cerebral cortex. Morphine was used as a μ-receptor agonist. There was a dose-dependent inhibition of the PGE1-stimulated cAMP accumulation by morphine, blocked by the μ-receptor antagonist naloxone. These findings suggest that these neuronal cultures express μ-receptors, possibly connected to adenylate cyclase via an inhibitory Gi-protein. The probable use of functional μ-receptors in neurotoxicological tests is discussed.


Life Sciences ◽  
1986 ◽  
Vol 38 (21) ◽  
pp. 1889-1898 ◽  
Author(s):  
Gavril W. Pasternak ◽  
Paul J. Wood

1991 ◽  
Vol 41 (10) ◽  
pp. 1534-1536 ◽  
Author(s):  
Linda Liu ◽  
Yeshayahu Katz ◽  
Ronit Weizman ◽  
Beno Rosenberg ◽  
Gavril W. Pasternak ◽  
...  

1986 ◽  
Vol 126 (1-2) ◽  
pp. 1-9 ◽  
Author(s):  
Francis Petit ◽  
Michel Hamon ◽  
Marie-Claude Fournie-Zaluski ◽  
Bernard P. Roques ◽  
Jacques Glowinski

1990 ◽  
Vol 517 (1-2) ◽  
pp. 236-244 ◽  
Author(s):  
Donald P. Cain ◽  
Francis Boon ◽  
Michael E. Corcoran
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document